GeNeuro from Switzerland raises €5M to advance Treatment Trials for Post-COVID Conditions
GeNeuro, a Geneva-based biopharmaceutical company, has successfully raised €5M through a combination of a private placement and a public offering. This funding will accelerate the company's Phase 2 trial in Post-COVID treatment, marking a significant step forward in addressing the long-term effects of COVID-19.
Episode 1, a venture capital firm based in London, has successfully closed its third early-stage fund at £76 million (approximately €88.72 million). This new fund includes a significant £20 million (nearly €23.34 million) cornerstone commitment from British Patient Capital and the National Security Strategic Investment Fund, positioning Episode 1 to
The French startup Naboo, likened to the Booking.com for corporate seminars, has successfully raised €9 million in funding. This investment round was led by ISAI and Kima Ventures, with participation from Better Angle, CapHorn, and Maif Avenir. Naboo's innovative platform is designed to streamline the process of organizing corporate seminars,

The best Articles in our Network